跳至主要内容
临床试验/NCT02739269
NCT02739269已完成不适用

A Randomised Trial to Compare Antral Follicle Count and Serum Anti-Mullerian Hormone Level for Determination of Gonadotrophin Dosing in In-vitro Fertilisation

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年4月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Percentage of Subjects Having Desired Ovarian Response

研究概览

简要总结

This is a prospective randomized trial to compare the use of AFC and serum AMH as the basis for gonadotrophin dosing in in-vitro fertilization treatment.

The hypothesis is that the use of serum AMH as the criterion for determination of gonadotrophin dosing in IVF treatment results in more optimal ovarian response than AFC.

详细描述

Patients undergoing the first-time IVF treatment cycle using either conventional insemination technique or intracytoplasmic sperm injection at Queen Mary Hospital will be invited to participate in this study. Participating subjects will be randomized into either (i) AFC or (ii) AMH group, where the gonadotrophin dosing will be determined based on the baseline AFC and serum AMH respectively as assessed one month before the IVF treatment. Randomisation will be performed according to a computer-generated list which will be read by an independent research nurse. That research nurse will assign the initial gonadotrophin dose according to the study protocol.

In the AFC group, starting dose of gonadotrophin will be determined based on serum AMH concentration as follows:

AFC <= 5: 300 IU daily AFC >5 and <=15: 225 IU daily AFC >15: 150 IU daily

In the AMH group, starting dose of gonadotrophin will be determined based on serum AMH concentration as follows:

AMH <= 1.0 ng/ml: 300 IU daily AMH >1.0 and <=3.3 ng/ml: 225 IU daily AMH >3.3 ng/ml: 150 IU daily

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects undergoing the first IVF cycle during the study period.

排除标准

  • Body mass index >=30 kg/m2
  • Subjects in repeated IVF cycles
  • Subjects undergoing IVF treatment using donor oocytes
  • Subjects undergoing pre-implantation genetic diagnosis

结局指标

主要结局

Percentage of Subjects Having Desired Ovarian Response

时间窗: One single time point, i.e. at the time of oocyte retrieval

Percentage of subjects with number of oocytes retrieved being between 6 and14

次要结局

  • Percentage of Subjects Requiring Step-up or Step-down of Gonadotrophin Dose Upon First Ultrasound Tracking(8th day of ovarian stimulation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Hang Wun Raymond Li

Associate Professor

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验